References
- Hedestig O, Sandman P-O, Tomic R, Widmark A. Living after external beam radiotherapy for localized prostate cancer. A qualitative analysis of patient narratives. Cancer Nurs 2005; 28: 310–17
- Hedestig O, Sandman P-O, Tomic R, Widmark A. Living after radical operation for localized prostate cancer. A qualitative analysis of patient narratives. Acta Oncol 2005; 44: 679–86
- Livingstone P, Cohen P, Frydenberg M, Borland R, Reading D, Clarke W, et al. Knowledge, attitudes and experience associated with testing for prostate cancer: a comparison between male doctors and men in the community. Int Med J 2002; 32: 215–23
- Korfage IJ, de Koning HJ, Roobol M, Schröder FH, Essink-Bot M-L. Prostate cancer diagnosis: the impact on patients’ mental health. Eur J Cancer 2006; 42: 165–70
- Llorente MD, Burke M, Gregory GR, Bosworth H, Grambow SC, Horner RD, et al. Prostate cancer, a significant risk factor for late-life suicide. Am J Geriatr Psychiatry 2005; 13: 195–201
- Stamey TA, Yang N, Hay AR, McNeal JE, Freiha FS, Redwine E. Prostate-specific antigen as a serum marker for adenocarcinoma of the prostate. N Engl J Med 1987; 317: 909–16
- Draisma G, Boer R, Otto SJ, van der Cruijsen IW, Damhuis RA, Scroder FH, et al. Lead times and overdetection due to prostate-specific antigen screening: estimates from the European randomized study of screening prostate cancer. J Natl Cancer Inst 2003; 95: 868–78
- Crook JM, Choan EG, Perry A, Robertsson S, Esche BA. Serum prostate-specific antigen profile following radiotherapy for prostate cancer: implications for patterns of failure and definition of cure. Urology 1998; 51: 566–72
- Pound CR, Partin AW, Eisenberg MA, Chan DW, Pearson JD, Walsh PL. Natural history of progression after PSA elevation following radical prostatectomy. JAMA 1999; 281: 1591–7
- Freedland SJ, Humphreys EB, Mangold LA, Eisenberger M, Dorey FJ, Walsh PC, et al. Risk of prostate cancer-specific mortality following biochemical recurrence after radical prostatectomy. JAMA 2005; 294: 433–9
- Taylor JMG, Yu M, Sandler HM. Individualized predictors of disease progression following radiation therapy for prostate cancer. J Clin Oncol 2005; 23: 816–25
- Klotz L. Active surveillance with selective delayed intervention using PSA doubling time for good risk prostate cancer. Eur Urol 2005; 47: 16–21
- Metha SS, Lubeck DP, Pasta DJ, Litwin MS. Fear of cancer recurrence in patients undergoing definitive treatment for prostate cancer: results from CaPSURE. J Urol 2003; 170: 1931–3
- Sachs L. The diagnosis of risk—implications for the quality of life. Cancer, AIDS and the quality of life, J Levy, C Jasmin, G Bez. Plenum Press, New York 1997
- Forss A, Tishelman C, Widmark C, Sachs L. Women's experiences of cervical cellular changes: an unintentional transition from health to liminality?. Sociol Health Illn 2004; 26: 306–25
- Hedestig O, Sandman PO, Widmark A. Living with untreated localized prostate cancer. A qualitative analysis of patient narratives. Cancer Nurs 2003; 26: 55–60
- Mischler EG. Research interviewing: content and narrative. Harvard University Press, Cambridge, MA 1996
- Ricoeur P. Interpretation theory: discourse and the surplus of meaning. Christian University Press, Fort Worth, TX 1976
- Lindseth A, Norberg A. A phenomenological hermeneutical method for researching lived experience. Scand J Caring Sci 2004; 18: 145–53
- Rasmussen B, Sandman PO, Norberg A. Stories of being a hospice nurse: a journey towards finding one's footing. Cancer Nurs 1997; 20: 330–41
- Söderberg A, Gilje F, Norberg A. Transforming desolation into consolation: the meaning of being in situations of ethical difficulty in intensive care. Nurs Ethics 1999; 6: 357–73
- Ricoeur P. From text to action. In: Kemp P, Kristensson B, translators/editors. An anthology about hermeneutics, 4th ed. Stockholm/LundSweden: Symposium Förlag; 1993.
- Forss A, Tishelman C, Widmark C, Lundgren E-L, Sachs L, Törnberg S. “I got a letter …” a qualitative study of women's reasoning about attendance in a cervical cancer screening programme in urban Sweden. Psychooncology 2001; 10: 76–87
- Kavanagh AM, Broom DH. Women's understanding of abnormal cervical smear test results: a qualitative interview study. Br Med J 1997; 314: 1388–91
- Taylor SE. Adjustment to threatening events. A theory of cognitive adaptation. Am Psychol 1983; 38: 1161–73
- Taylor SE, Lichtman RR, Wood JV. Attributions, beliefs about control, and adjustment to breast cancer. J Pers Soc Psychol 1984; 46: 489–502
- Taylor SE, Helgeson VS, Reed GM, Skokan LA. Self-generated feelings of control and adjustment to physical illness. J Soc Issues 1991; 47: 91–109
- Thompson SC, Sobolew-Shubin A, Galbraith ME, Schwankovsky L, Cruzen D. Maintaining perceptions of control: finding perceived control in low-control circumstances. J Pers Soc Psychol 1993; 64: 293–304
- Newsom JT, Knapp JE, Scultz R. Longitudinal analysis of specific domains of internal control and depressive symptoms in patients with recurrent cancer. Health Psychol 1996; 15: 323–31
- Grassi L, Rosti G. Psychosocial morbidity and adjustment to illness among long-term cancer survivors. A six-year follow up study. Psychosomatics 1996; 37: 523–32
- McGovern P, Gross CR, Krueger RA, Egelhard D, Cordes JE, Church TR. False-positive cancer screens and health-related quality of life. Cancer Nurs 2004; 27: 347–52
- Lofters A, Juffs HG, Pond GR, Tannock IF. “PSA-itis”: knowledge of serum prostate specific antigen and other causes of anxiety in men with metastatic prostate cancer. J Urol 2002; 168: 2516–20